The mRNA Technology Transfer Programme is a global initiative that aims to improve health and health security by establishing sustainable, locally owned mRNA manufacturing capabilities in and for low- and middle-income countries (LMICs).The Programme is based around a technology transfer “hub”, which is located in South Africa. They will provide the technology development, training and technology transfer, and currently 15 Programme Partners in LMICs across the world are receiving training and technology from Afrigen – the Centre for mRNA technology development and transfer – and will then produce and sell products commercially. Its core concept is empowerment.
While the Programme was initially focusing on mRNA vaccines against COVID-19, it has been designed to encourage the development of other mRNA vaccines and therapeutics against important diseases that threaten LMICs, thereby ensuring the capacity built by the project is sustained and available to combat the next pandemic.
(click here for full-width experience)
News & Press Releases » Press Releases
13 Jun 2025
News & Press Releases » Events
19 May 2025
07 Mar 2025
11 Feb 2025
News & Press Releases » Events, mRNA
05 Dec 2024
News & Press Releases » Events, News & Press Releases » News, News & Press Releases » Press Releases, mRNA
20 Nov 2024
News & Press Releases » News, mRNA
29 Jul 2024
22 Feb 2024
27 Nov 2023
01 Sep 2023
News & Press Releases
22 May 2023
News & Press Releases » News
20 Apr 2023
10 Mar 2023
08 Dec 2022